Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MediXall (MDXL) Share-based Compensation (2019 - 2023)

MediXall's Share-based Compensation history spans 6 years, with the latest figure at $155994.0 for Q4 2023.

  • For Q4 2023, Share-based Compensation fell 79.12% year-over-year to $155994.0; the TTM value through Sep 2024 reached $155994.0, down 92.75%, while the annual FY2023 figure was $1.6 million, 20.61% down from the prior year.
  • Share-based Compensation reached $155994.0 in Q4 2023 per MDXL's latest filing, down from $467982.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $1.1 million in Q1 2022 to a low of -$242700.0 in Q3 2022.
  • Average Share-based Compensation over 5 years is $476649.6, with a median of $467982.0 recorded in 2023.
  • Peak YoY movement for Share-based Compensation: skyrocketed 347.09% in 2021, then tumbled 2527.0% in 2022.
  • A 5-year view of Share-based Compensation shows it stood at $598251.0 in 2019, then plummeted by 74.79% to $150844.0 in 2020, then surged by 347.09% to $674407.0 in 2021, then grew by 10.8% to $747237.0 in 2022, then plummeted by 79.12% to $155994.0 in 2023.
  • Per Business Quant, the three most recent readings for MDXL's Share-based Compensation are $155994.0 (Q4 2023), $467982.0 (Q3 2023), and $467982.0 (Q2 2023).